GT reports Q1 results on May 7 carrying a clear tension: the stock has recovered modestly from its lows, but short sellers have been quietly rebuilding positions even as price improved, and the analyst community has spent the past two weeks trimming targets without abandoning their constructive ratings.
Short interest has climbed steadily since late April and now sits at just above 10% of the free float — up roughly 7.4% on the month and 2.3% on the week. That follows a notable step-up in mid-April, when SI peaked near 11.3% before the stock found some footing. The partial cover that happened between April 10 and April 24 has since partially reversed. At those levels, one-in-ten float shares is short — material for a single-digit stock with $5.2bn in net debt. The ORTEX short score reads 53, a middling level that has been drifting up over the past two weeks, confirming the trend of quiet accumulation. Borrow is not the constraint: cost to borrow is under 0.5% and availability remains loose, meaning new shorts face no friction entering the trade.
Options traders are not adding much urgency to either side. The put/call ratio is 0.63, only fractionally above its 20-day average of 0.62 and less than one standard deviation from the mean. The 52-week range runs from 0.36 to 1.18, so the current reading is firmly within the neutral zone. The market is neither rushing to hedge nor expressing aggressive upside conviction ahead of the print.
The Street's direction of travel is unmistakable, even if ratings haven't moved. In mid-to-late April, JP Morgan cut its target from $11 to $10 while keeping Overweight, and Deutsche Bank trimmed from $12 to $9 while staying at Buy. TD Cowen likewise clipped to $9. The consensus mean price target is $8.73 against Tuesday's close of $7.08 — implied upside of roughly 23%, but that gap has been narrowing as firms walk targets down in response to the tariff-driven cost environment facing tire manufacturers. Morgan Stanley holds its Underweight with a $7.30 target, essentially at the current price. Valuation offers some ballast: EV/EBITDA is around 5x on estimated figures, and the price-to-book has crept up 30 days to roughly 0.60x — deep value territory, but with $5.2bn in net debt and $406m in annual interest expense, leverage remains the central bear argument.
The earnings history adds a sober layer. The February 2026 print triggered a 9.9% single-day drop and the stock fell another 5.8 points over the following week. The April 2026 event (an announcement pre-open) produced a milder 3.7% decline on the day, followed by a partial recovery of 1.7% over five sessions. Two consecutive post-earnings selloffs in the period immediately preceding this report means bulls need a clear beat and any constructive commentary on tariff pass-through or cost reduction to arrest the trend.
American Century added over 1.1 million shares in the most recent period, and Wellington took on 1.7 million. Those are meaningful additions at a stock trading around $7, and they sit against Maple Rock trimming by nearly 2.5 million. The ownership picture is one of passive and active rotation rather than a directional consensus. Insider activity is limited to routine director award grants in April and a small open-market sell by an independent director at $7.03 — nothing that signals either panic or opportunistic buying from those with the most visibility into the Q1 numbers.
What to watch on May 7: whether management quantifies the tariff cost impact and whether they affirm any medium-term EBITDA recovery path — those two data points will determine whether the shorts who have been quietly rebuilding at 10% of float face any pressure to cover.
See the live data behind this article on ORTEX.
Open GT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
